Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Wormald

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Eye (London, England)|March 30, 2024
Uniting vision data and moreCatey Bunce, Richard Wormald
JAMA Ophthalmology|October 7, 2017
Risk of Intraocular Bleeding and the New Anticoagulants: Not Such a Big EffectRichard Wormald, Jennifer Evans
JAMA Ophthalmology|August 21, 2015
Considerations for randomizing 1 eye or 2 eyesCatey Bunce, Richard Wormald
Community Eye Health|March 19, 2016
Preventing eye injuries in quarriesRichard Wormald, Daksha Patel
Community Eye Health|February 12, 2011
Clinical auditing to improve patient outcomesDavid Yorston, Richard Wormald
The British Journal of Ophthalmology|April 21, 2007
Topical azithromycin: new evidence?Hannah Kuper, Richard Wormald
Ophthalmology|November 20, 2013
Evidence-based ophthalmologyRichard Wormald, Kay Dickersin,
Ophthalmic Epidemiology|September 12, 2017
What Makes Systematic Reviews Systematic and Why are They the Highest Level of Evidence?Richard Wormald, Jennifer Evans
Clinical Evidence|January 18, 2005
GlaucomaRajiv Shah, Richard Wormald
BMC Public Health|March 10, 2006
Leading causes of certification for blindness and partial sight in England & WalesCatey Bunce, Richard Wormald
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Eye (London, England)|March 30, 2024
Uniting vision data and moreCatey Bunce, Richard Wormald
JAMA Ophthalmology|October 7, 2017
Risk of Intraocular Bleeding and the New Anticoagulants: Not Such a Big EffectRichard Wormald, Jennifer Evans
JAMA Ophthalmology|August 21, 2015
Considerations for randomizing 1 eye or 2 eyesCatey Bunce, Richard Wormald
Community Eye Health|March 19, 2016
Preventing eye injuries in quarriesRichard Wormald, Daksha Patel
Community Eye Health|February 12, 2011
Clinical auditing to improve patient outcomesDavid Yorston, Richard Wormald
The British Journal of Ophthalmology|April 21, 2007
Topical azithromycin: new evidence?Hannah Kuper, Richard Wormald
Ophthalmology|November 20, 2013
Evidence-based ophthalmologyRichard Wormald, Kay Dickersin,
Ophthalmic Epidemiology|September 12, 2017
What Makes Systematic Reviews Systematic and Why are They the Highest Level of Evidence?Richard Wormald, Jennifer Evans
Clinical Evidence|January 18, 2005
GlaucomaRajiv Shah, Richard Wormald
BMC Public Health|March 10, 2006
Leading causes of certification for blindness and partial sight in England & WalesCatey Bunce, Richard Wormald
Pageof 8